Skip to content

Radio Frequency in Peripheral Facial Nerve palsy(RaFace): a multicenter prospective cohort study

Radio Frequency in Peripheral Facial Nerve palsy(RaFace): a multicenter prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116039
Enrollment
Unknown
Registered
2026-01-05
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral facial paralysis

Interventions

Observation Group of radiofrequency Treatment for peripheral facial paralysis:None

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Subjects understand and sign the informed consent form; 2.Subjects aged >=18 years, no gender limitation; 3.Sunnybrook score 13-75; 4.Moderate to severe facial paralysis (Sunnybrook 13-75) persists after conservative treatment, course >2 weeks; 5.Peripheral facial paralysis caused by the following: including facial neuritis, facial paralysis due to cerebellopontine angle surgery, trauma, etc;

Exclusion criteria

Exclusion criteria: 1.Complete facial nerve transection; 2.Presence of contraindications to pulsed radiofrequency therapy; 3.Expected life expectancy less than 1 year; 4.Patients unable to cooperate with subsequent follow-up;

Design outcomes

Primary

MeasureTime frame
The proportion of patients with Sunnybrook score improvement=12 scores at 3 months after treatment with radiofrequency ablation (pulsed nerve modulation);

Secondary

MeasureTime frame
Trend of Sunnybrook scores with the number of treatments;Facial Disability Index (FDI) score;House-Brackmann grading system (H-BGS);Burres-Fisch facial nerve score;Treatment time required for Sunny brook score improvement to >75 points or HB score improvement to <= mild;AEs and SAEs during the follow-up period;

Countries

China

Contacts

Public ContactYanwu Guo;Jian Liu

Zhujiang Hospital of Southern Medical University

dguoyanwu@163.com+86 13711432687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026